Understanding linerixibat as a treatment for itch in people with primary biliary cholangitis: a plain language summary of the GLISTEN trial

Plain Language SummaryWhat is this summary about?This is a summary of a clinical trial called GLISTEN, which included people with primary biliary cholangitis (PBC) and itch. PBC is a liver disease where itching is a common symptom that can greatly reduce quality of life and often disrupts sleep. The study investigated if a treatment called linerixibat could help reduce itching and itch-related sleep disturbance in people with PBC.In this study, 238 people with PBC and itch were randomly assigned to receive either linerixibat or matching placebo (a tablet with no active medicine). Both groups took their tablets and recorded their itch twice per day. The main goal was to see how much itch improved, measured on a scale from 0 (no itching) to 10 (worst imaginable itching) over 24 weeks.What were the results?People taking linerixibat had reliably greater itch relief over 24 weeks compared with those taking placebo. Itching improved as early as Week 2 with linerixibat. People taking linerixibat also reported less sleep disturbance caused by itch over 24 weeks compared with those taking placebo. More people taking linerixibat experienced diarrhea and abdominal pain than those taking placebo. Most of these cases were mild or easy to manage, with very few people stopping treatment because of them.What do the results mean?Current guideline-recommended medicines for itch associated with PBC have limited evidence to support their benefit. Linerixibat is a promising treatment for itch in people with PBC, providing a specific treatment option for this burdensome symptom.How to say (download PDF and double click sound icon to play sound)…Biliary: bil-ee-air-reeCholangitis: co-lan-jai-tusLinerixibat: lin-eh-rix-i-batPruritus: proo-rye-tusClinical trial: A research study carried out with volunteers to test the benefits and risks of a potential treatment in people with a specific disease. Clinical trials follow strict rules and guidelines to make sure the results are reliable and that the people taking part are protected.Quality of life: In medicine, it is a measure of a person’s overall physical, mental, and social well-being and ability to function when they are living with a disease. It measures how a person feels about their own physical and mental health.This is an abstract of the Plain Language Summary of Publication article.